Package Leaflet: Information for the User
Finasteride Combix 1mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
-This medicine has been prescribed for you only. Do not give it to others even if they have similar symptoms to you, as it may harm them.
Finasterida contains the active ingredient finasteride.
Finasterida is for exclusive use in males.
Finasterida is used for the treatment of male pattern hair loss (also known as androgenetic alopecia) in males aged 18 to 41 years. If after reading this leaflet, you have any questions about male pattern hair loss, consult your doctor.
Male pattern hair loss is a common disorder believed to be caused by a combination of genetic factors and a particular hormone, called dihydrotestosterone (DHT). DHT contributes to shortening the hair growth phase and making the hair thinner.
In the scalp, finasteride specifically reduces DHT levels by blocking an enzyme (Type II 5-alpha-reductase) that converts testosterone to DHT. Only males with mild to moderate hair loss, but not complete, can expect a benefit from using finasteride. In many males treated with finasteride for 5 years, the progression of hair loss became slower, and at least half of those males also showed some improvement in hair growth.
Do not takeFinasterida Combix
Warnings and precautions
Consult your doctor or pharmacist before starting to take Finasterida Combix
Effects on Prostate-Specific Antigen (PSA)
Finasteride may affect a blood test called Prostate-Specific Antigen (PSA) for detecting prostate cancer. If you have had a PSA test, you must inform your doctor or pharmacist that you are taking finasteride, as it decreases PSA levels.
Effects on fertility
Infertility has been reported in men who took finasteride for a long time and had other risk factors that could affect fertility. Normalization or improvement of semen quality has been reported after stopping finasteride treatment. No long-term clinical studies have been conducted on the effect of finasteride on male fertility.
Breast cancer
See section 4.
Mood changes and depression
Mood changes, such as depressed mood, depression, and, less frequently, suicidal thoughts have been reported in patients treated with finasteride. If you experience any of these symptoms, stop taking finasteride and consult your doctor as soon as possible for medical advice.
Children and adolescents
Finasteride should not be used in children. There is no evidence to demonstrate the efficacy and safety of finasteride in children under 18 years old.
Other medications and Finasterida Combix
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Pregnancy, breastfeeding, and fertility
Finasteride is intended for the treatment of male pattern hair loss exclusively in males. For the effects on male fertility, see section 2.
In case of doubt, ask your doctor.
Driving and operating machines
There is no evidence to indicate that finasteride affects the ability to drive or operate machines.
Finasterida Combix contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medication.
Finasterida Combix contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is one tablet per day. Tablets can be taken with or without food.
Your doctor will help you determine if finasteride works for you. It is important to take finasteride for the entire time your doctor tells you to. Finasteride only acts in the long term if its administration is maintained.
If you take more Finasterida Combix than you should
If you accidentally take too many tablets, go to your doctor immediately. Finasteride will not act faster or better by taking more than one tablet per day.
Consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forgot to take Finasterida Combix
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Finasterida Combix
To appreciate the effect, it may be necessary to take the medication for 3 to 6 months. It is essential that you try to take finasteride for the entire period of time indicated by your doctor. If you stop taking finasteride, you will probably lose the hair you gained in the 9 to 12 months following the interruption of treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may produce adverse effects, although not everyone will experience them.
Adverse effects have been, normally, transient with continued treatment or have disappeared when treatment is interrupted.
Stop taking finasteride and immediately inform your doctor if you experience any of the following symptoms: swelling of the lips, face, tongue, and throat; difficulty swallowing; lumps under the skin (hives) and difficulty breathing.
You must immediately inform your doctor of any change in breast tissue, such as lumps, pain, increased breast tissue, or nipple discharge, as these may be signs of a serious disease, such as breast cancer.
Rare: may affect up to 1 in 100 people
Frequency unknown: the frequency cannot be estimated from available data
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Finasterida Combix
Core of the tablet:monohydrate lactose,carboxymethylcellulose sodium type A,pregelatinized cornstarch, sodium docusate, microcrystalline cellulose, magnesium stearate.
Covering:hypromellose, hydroxypropyl cellulose, titanium dioxide (E171), talc, iron oxide red (E172), iron oxide yellow (E172)).
Appearance of the product and contents of the packaging
Finasterida Combix is a film-coated tablet, brown in color, round, biconvex, and smooth on both sides, with an approximate diameter of 6.4 mm. The tablets are presented in blisters available in packaging of 28 and 98 tablets.
Only some sizes of packaging may be commercially available.
Holder of the marketing authorization
Combix Laboratories, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Responsible for manufacturing
Zydus France
ZAC Les Hautes Patures
Parc d'activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
O
Centre Spécialités Pharmaceutiques
ZAC des Suzots
35 rue de la Chapelle
63450 Saint Amant Tallende
France
O
Netpharmalab Consulting Services
Carretera de Fuencarral 22
28108 Alcobendas, Madrid
Spain
O
Pharmex Advanced Laboratories S.L.
Ctra. A-431 Km. 19
14720 Almodóvar del Río (Córdoba)
Spain
O
Flavine Pharma France
3 Voie d’Allemagne
13127 Vitrolles
France
Last review date of this leaflet:October 2022
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.